Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis

Psoriasis is an immune-mediated skin disease with various presentations. HIV infection affects the immune system and aggravates psoriasis lesions. Therefore, psoriasis management in HIV patients poses a great challenge for dermatologists. In this report, 2 HIV patients with erythrodermic psoriasis r...

Full description

Bibliographic Details
Main Authors:	Mary Catherine G. Pangilinan, Peerada Sermswan, Pravit Asawanonda
Format:	Article
Language:	English
Published:	Karger Publishers 2020-08-01
Series:	Case Reports in Dermatology
Subjects:	biologic treatment ixekizumab secukinumab hiv psoriasis anti-il-17 erythrodermic psoriasis
Online Access:	https://www.karger.com/Article/FullText/508781

id	doaj-05f9faf245a74ceabc7ab94ae7920abb
record_format	Article
spelling	doaj-05f9faf245a74ceabc7ab94ae7920abb2020-11-25T03:44:59ZengKarger PublishersCase Reports in Dermatology1662-65672020-08-0112213213710.1159/000508781508781Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic PsoriasisMary Catherine G. PangilinanPeerada SermswanPravit AsawanondaPsoriasis is an immune-mediated skin disease with various presentations. HIV infection affects the immune system and aggravates psoriasis lesions. Therefore, psoriasis management in HIV patients poses a great challenge for dermatologists. In this report, 2 HIV patients with erythrodermic psoriasis received anti-IL-17 and experienced significant clearance of lesions. No recurrence or opportunistic infection was noted. In conclusion, anti-IL-17 monoclonal antibodies are an effective and promising treatment option for HIV-infected patients with psoriasis.https://www.karger.com/Article/FullText/508781biologic treatmentixekizumabsecukinumabhiv psoriasisanti-il-17erythrodermic psoriasis
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Mary Catherine G. Pangilinan Peerada Sermswan Pravit Asawanonda
spellingShingle	Mary Catherine G. Pangilinan Peerada Sermswan Pravit Asawanonda Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis Case Reports in Dermatology biologic treatment ixekizumab secukinumab hiv psoriasis anti-il-17 erythrodermic psoriasis
author_facet	Mary Catherine G. Pangilinan Peerada Sermswan Pravit Asawanonda
author_sort	Mary Catherine G. Pangilinan
title	Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
title_short	Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
title_full	Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
title_fullStr	Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
title_full_unstemmed	Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
title_sort	use of anti-il-17 monoclonal antibodies in hiv patients with erythrodermic psoriasis
publisher	Karger Publishers
series	Case Reports in Dermatology
issn	1662-6567
publishDate	2020-08-01
description	Psoriasis is an immune-mediated skin disease with various presentations. HIV infection affects the immune system and aggravates psoriasis lesions. Therefore, psoriasis management in HIV patients poses a great challenge for dermatologists. In this report, 2 HIV patients with erythrodermic psoriasis received anti-IL-17 and experienced significant clearance of lesions. No recurrence or opportunistic infection was noted. In conclusion, anti-IL-17 monoclonal antibodies are an effective and promising treatment option for HIV-infected patients with psoriasis.
topic	biologic treatment ixekizumab secukinumab hiv psoriasis anti-il-17 erythrodermic psoriasis
url	https://www.karger.com/Article/FullText/508781
work_keys_str_mv	AT marycatherinegpangilinan useofantiil17monoclonalantibodiesinhivpatientswitherythrodermicpsoriasis AT peeradasermswan useofantiil17monoclonalantibodiesinhivpatientswitherythrodermicpsoriasis AT pravitasawanonda useofantiil17monoclonalantibodiesinhivpatientswitherythrodermicpsoriasis
_version_	1724512247290527744

Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis

Similar Items